Table I.
Association between the clinicopathological factors of the NSCLC patients and OSER1-AS1 expression.
| OSER1-AS1 expression (n=53) | |||
|---|---|---|---|
| Clinicopathological factors | High (n=27) | Low (n=26) | P-value |
| Sex | 0.782 | ||
| Male | 12 | 10 | |
| Female | 15 | 16 | |
| Age (years) | 0.264 | ||
| <65 | 8 | 12 | |
| ≥65 | 19 | 14 | |
| Classification | 0.553 | ||
| Adenocarcinoma | 11 | 9 | |
| Squamous | 12 | 15 | |
| Large cell | 4 | 2 | |
| Differentiation | 0.782 | ||
| Well + Moderate | 10 | 11 | |
| Poor | 17 | 15 | |
| Tumor size (cm) | 0.024 | ||
| <3 | 12 | 20 | |
| ≥3 | 15 | 6 | |
| TNM stage | 0.028 | ||
| I–II | 8 | 16 | |
| III–IV | 19 | 10 | |
| Lymph node metastasis | 0.045 | ||
| Negative | 13 | 20 | |
| Positive | 14 | 6 | |
NSCLC, non-small cell lung cancer; OSER1-AS1, OSER1 antisense RNA 1. P-values in bold print indicate significant differences.